OncoTherics is a new pharmaceutical company, focusing on the development of novel hypoxia-activated pro-drugs for the treatment of a wide range of cancers... The company was formed as a spin-out from BioStatus, to progress a novel small molecule, code-named OCT1002. The company is at an early stage but the patented technology has a unique history allowing a more rapid than usual progression through the clinical trial process. For further information, please contact us using the contact form provided on this site ...
View Top Employees from OncoTherics| Website | http://www.oncotherics.com |
| Revenue | $4 million |
| Employees | 6 (3 on RocketReach) |
| Founded | 2009 |
| Phone | +44 1509 558163 |
| Technologies |
JavaScript,
HTML,
Twitter
+10 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Business Services General, Hypoxia activated prodrugs for the treatment of cancer, Business Services |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies |
Looking for a particular OncoTherics employee's phone or email?
OncoTherics Questions
The OncoTherics annual revenue was $4 million in 2024.
Roland Kozlowski is the Executive Chairman of OncoTherics.
3 people are employed at OncoTherics.
The NAICS codes for OncoTherics are [54, 541, 5417, 54171, 541714].
The SIC codes for OncoTherics are [87, 873].
Top OncoTherics Employees
-
31
-
ViewThomas Morris
Chief Medical Officer at OncoTherics
Nether Alderley, Cheshire East, United Kingdom21 -
44
Related Companies
